Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Since no response, I'm reposting the message. I think the cash from a possible IST deal for head and neck cancer could be the only force that may overcome the gravity in the near future. Any ideas?
------------------------------------

Since there has been a lot of back and forth conversations re: IST for HPV+ H&N cancer to start this year, I felt confused when some posters here suggested that this deal would resolve all cash worries for ADXS. I started looking at those investigator sponsored trials, and this is what I see. All of the deals via IST route do not bring any upfront cash, rather they alleviate a cash burden for the sponsors. Am I reading this correctly? Does anyone have some first hand experience in this area?